Literature DB >> 8161259

Surgical treatment of primary hyperaldosteronism.

R J Weigel1, S A Wells, J C Gunnells, G S Leight.   

Abstract

OBJECTIVE: A retrospective review of patients with primary hyperaldosteronism treated at the Duke University Medical Center was performed. SUMMARY BACKGROUND DATA: The management of patients with primary hyperaldosteronism has changed dramatically in the past 20 years. The outcome of surgical treatment was examined to optimize the management of these patients.
METHODS: All patients who were evaluated for primary hyperaldosteronism before operation and who had adrenal surgery at Duke University Medical Center from 1970 to 1993 were included in the study.
RESULTS: A ratio of plasma aldosterone concentration to plasma renin activity greater than 250 was predictive of hyperaldosteronism in 94% of patients. This ratio also predicted the size of the adenoma. Surgical treatment cured hypokalemia in 90% of the patients. Hypertension was cured or greatly improved, with an average decrease of 50.4 mmHg and 25.2 mmHg for systolic and diastolic pressures, respectively. Patients who had hypertension for less than 5 years achieved a satisfactory blood pressure response more often (13 of 14 patients) than did patients who had hypertension for 5 or more years (15 of 20 patients).
CONCLUSIONS: Preoperative evaluation of patients with primary hyperaldosteronism using current modes allows a posterior approach to be used in most patients. Adrenalectomy cures hypokalemia and hypertension; however, patients with a history of hypertension for less than 5 years may be more likely to be cured by adrenal resection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161259      PMCID: PMC1243150          DOI: 10.1097/00000658-199404000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

Review 1.  CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

Authors:  J W CONN; R F KNOPF; R M NESBIT
Journal:  Am J Surg       Date:  1964-01       Impact factor: 2.565

2.  Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-01

3.  Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.

Authors:  Y Takeda; I Miyamori; K Iki; R Takeda; P Vecsei
Journal:  Acta Endocrinol (Copenh)       Date:  1992-06

4.  Hypertension, adrenal abnormalities, and alterations in plasma renin activity.

Authors:  J C Gunnells; W L McGuffin; R R Robinson; C E Grim; S Wells; D Silver; J F Glenn
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

Review 5.  Primary aldosteronism: diagnosis and treatment.

Authors:  W F Young; M J Hogan; G G Klee; C S Grant; J A van Heerden
Journal:  Mayo Clin Proc       Date:  1990-01       Impact factor: 7.616

6.  Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.

Authors:  J B Ferriss; J J Brown; R Fraser; E Haywood; D L Davies; A W Kay; A F Lever; J I Robertson; K Owen; W S Peart
Journal:  Br Med J       Date:  1975-01-18

Review 7.  Primary hyperaldosteronism.

Authors:  R H Noth; E G Biglieri
Journal:  Med Clin North Am       Date:  1988-09       Impact factor: 5.456

8.  Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein cateterization.

Authors:  J C Melby; R F Spark; S L Dale; R H Egdahl; P C Kahn
Journal:  N Engl J Med       Date:  1967-11-16       Impact factor: 91.245

9.  Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism.

Authors:  I Miyamori; Y Takeda; H Takasaki; Y Itoh; K Iki; R Takeda
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

10.  Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma.

Authors:  Y Ito; Y Fujimoto; T Obara; T Kodama
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

View more
  14 in total

1.  Transcatheter alcohol embolization of an aldosteronoma.

Authors:  Michael W D'Angelo
Journal:  Semin Intervent Radiol       Date:  2007-03       Impact factor: 1.513

2.  Is hyperaldosteronism a pathognomonic feature of conn's syndrome?

Authors:  R Nagarajan; K Kuberan; M S Senthil Kumar; M Chandrasekaran
Journal:  Indian J Surg       Date:  2010-07-01       Impact factor: 0.656

3.  Long-term follow-up after adrenalectomy for primary aldosteronism.

Authors:  Andreas Meyer; Georg Brabant; Matthias Behrend
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

Review 4.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

Review 5.  Primary aldosteronism. Results of surgical treatment.

Authors:  C Y Lo; P C Tam; A W Kung; K S Lam; J Wong
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

Review 6.  Treatment of primary aldosteronism: Where are we now?

Authors:  Asterios Karagiannis
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

7.  Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.

Authors:  David C Kem; Hongliang Li; Carolina Velarde-Miranda; Campbell Liles; Megan Vanderlinde-Wood; Allison Galloway; Muneer Khan; Caitlin Zillner; Alexandria Benbrook; Veitla Rao; Celso E Gomez-Sanchez; Madeleine W Cunningham; Xichun Yu
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

Review 8.  [Adrenalectomy for preservation of adrenocortical function. Indication and results].

Authors:  M K Walz
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

9.  Endocrine hypertension secondary to adrenal tumors: clinical course and predictive factors of clinical remission.

Authors:  Uriel Clemente-Gutiérrez; Rafael H Pérez-Soto; Juan D Hernández-Acevedo; Nicole M Iñiguez-Ariza; Enrique Casanueva-Pérez; Juan Pablo Pantoja-Millán; Mauricio Sierra-Salazar; Miguel F Herrera; David Velázquez-Fernández
Journal:  Langenbecks Arch Surg       Date:  2021-06-23       Impact factor: 3.445

10.  The Management of Primary Hyperaldosteronism in a Poor Technology Environment.

Authors:  Jean Sossa; Dedjinnin Josue Georges Avakoudjo; Dodji Magloire Ines Yevi; Lionelle Fanou; Gilles Natchagande; Michel Michael Agounkpe; Fred Hodonou; Yao Felicien Hounto; Felix Atadokpede
Journal:  Case Rep Urol       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.